NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells.
Jin Zheng(Shanghai University of Traditional Chinese Medicine), Wenchao Liu(University of Chicago), Heng-jun Shi(Tang Du Hospital), Ning Jiang(Zhujiang Hospital), Yurong Tao, Libo Yao(Civil Aviation University of China), Jin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qiang Liu(Sun Yat-sen University), Rui Zhang(Air Force Medical University), Hang Guo(Second Affiliated Hospital of Jilin University), Yan Li(The University of Texas Southwestern Medical Center), Jiandong Yang(National Institute on Aging), Ji Ma(Northwest A&F University), Xue Yan(Wuhan University), Fang Yu, Qinyou Ren(Tang Du Hospital)
PubMed
January 1, 2010
Cited by 20
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
|Nature Communications|2018|525
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
|Nature Communications|2021|414